The Global Small Animal Imaging In Vivo Market Size is valued at 2.36 billion in 2022 and is predicted to reach 5.11 billion by the year 2031 at a 9.16% CAGR during the forecast period for 2023-2031.
As technology continues to advance, multimodal instruments are being developed and used at a rapid rate in both preclinical and clinical settings. In addition, SPECT/CT scanners are increasingly frequently utilized for regular analysis. Dual-modality or hybrid PET/CT scanners are favored systems for clinical nuclear medicine. These multimodal devices benefit from combining the functional strength of one technology, such SPECT and PET, with the high-resolution anatomical imaging provided by CT or MRI.
Recent improvements in preclinical in-vivo modalities include PET/CT, PET/MRI, and SPECT/CT. The development of the market is greatly influenced by technological improvements. The M2 3D MR-based histology system, for example, was introduced by Aspect Imaging for in-vivo and ex-vivo toxicological imaging.
For high-throughput in-vivo and ex-vivo imaging of preclinical subjects, the M2 3D MR-based histology system is a portable, multimodal, and high-resolution MRI device. High-resolution 3D images of internal and anatomical morphology, as well as quantitative data on illness development and regression, are just a few of the many advantages of MRI that the M2 offers.
The Small Animal Imaging In Vivo market is categorized on the basis of technology and application. Based on technology, the market is segregated as Micro-MRI, Optical, Nuclear imaging, Micro-ultrasound. The application segment includes Cancer cell detection, Bio-distribution, Monitoring Therapy Response, Longitudinal Studies, Epigenetic Studies.
The optical segment category is expected to hold a major share in the global Small Animal Imaging In Vivo market in 2021. Since that operates quickly and simply and is more cost-effective than other modalities, optical imaging accounted for the highest revenue category. Due to features like precise and targeted operations that aid in producing better outcomes in preclinical research, micro-MRI technology is anticipated to see the greatest CAGR during the forecast period.
The two biggest application sectors are bio-distribution and tracking the treatment's effectiveness. The largest segment, bio-distribution, is anticipated to continue on its current trajectory during the projected period. In order to determine medication efficacy, optimize drug formulations, and identify acceptable profiles, drug-target engagement assessment of novel compounds or preclinical bio-distribution is essential. Non-invasive near-infrared (NIR) fluorescence imaging allows for real-time observation and detection of a new drug's bio-distribution across the entire body.
The region that brought in the most money was North America. Innovative modality innovations brought on by technological advancements are to blame for the market development in the area. Several preclinical studies conducted throughout the region are anticipated to aid the market's growth during the forecast period significantly. The presence of numerous producers of diagnostic devices, clinical research organizations, and pharmaceutical companies is expected to make Europe the second-largest market throughout the projection period. Due to the shifting of clinical research efforts from developed to developing countries, the Asia Pacific region is predicted to increase at the quickest rate during the projection period.
|
Report Attribute |
Specifications |
|
Market size value in 2022 |
USD 2.36 Bn |
|
Revenue forecast in 2031 |
USD 5.11 Bn |
|
Growth rate CAGR |
CAGR of 9.16 % from 2023 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Billion, and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Technology and Application |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Bruker (US), General Electric (US), Koninklijke Philips N.V. (Netherlands), Hitachi Ltd. (Japan), Siemens Healthcare GmbH (Germany), FUJIFILM Corporation (Japan), Bruker (US), PerkinElmer Inc (US), Miltenyi Biotec (Germany), CMR Naviscan (US), SCANCO Medical AG (Switzerland), Aspect Imaging Ltd (Israel). |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Small Animal Imaging In Vivo Market Snapshot
Chapter 4. Global Small Animal Imaging In Vivo Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technology Type Estimates & Trend Analysis
5.1. by Technology Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology Type:
5.2.1. Micro-MRI
5.2.2. Optical
5.2.3. Nuclear imaging
5.2.4. Micro-ultrasound
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Cancer cell detection
6.2.2. Bio-distribution
6.2.3. Monitoring Therapy Response
6.2.4. Longitudinal Studies
6.2.5. Epigenetic Studies
Chapter 7. Small Animal Imaging In Vivo Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2023-2031
7.1.2. North America Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.1.3. North America Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.2. Europe
7.2.1. Europe Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2023-2031
7.2.2. Europe Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.2.3. Europe Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2023-2031
7.3.2. Asia Pacific Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.3.3. Asia Pacific Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.4. Latin America
7.4.1. Latin America Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2023-2031
7.4.2. Latin America Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.4.3. Latin America Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2023-2031
7.5.2. Middle East & Africa Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.5.3. Middle East & Africa Small Animal Imaging In Vivo Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Aspect Imaging Ltd.
8.2.2. Bruker Corporation
8.2.3. CMR Naviscan (US)
8.2.4. FUJIFILM Holdings Corporation
8.2.5. General Electric (US)
8.2.6. Hitachi Ltd. (Japan)
8.2.7. Koninklijke Philips N.V. (Netherlands)
8.2.8. Life Technologies Corporation
8.2.9. Mediso Medical Imaging Systems
8.2.10. Miltenyi Biotech GmbH
8.2.11. PerkinElmer, Inc.
8.2.12. Promega Corporation
8.2.13. SCANCO Medical AG (Switzerland)
8.2.14. Siemens Healthcare GmbH (Germany)
8.2.15. Thermo Fisher Scientific
8.2.16. Other Prominent Players
Small Animal Imaging In Vivo Market By Technology-
Small Animal Imaging In Vivo Market By Application-
Small Animal Imaging In Vivo Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
